Get the app!
Back to Trades

Taub Rebecca

DirectorCIK 0001423898

Largest Purchase

No open-market purchases in the recent filings.

Profile

Filings
10
Buy transactions
0
Sell transactions
64
Companies
1
Active
2025–2026

Taub Rebecca, Director, has filed 10 SEC reports (2025–2026), all concentrated in MADRIGAL PHARMACEUTICALS, INC. (MDGL), totaling $51.8M in disclosed volume. Weighing $0 bought versus $48.8M sold, the history is heavily weighted toward selling. Data is sourced from official SEC Form 3, 4, and 5 filings.

Trading History

10 loaded
Jun 18MDGL
MADRIGAL PHARMACEUTICALS, INC.
Taub RebeccaDirectorGrant$382.9K
Mar 6MDGL
MADRIGAL PHARMACEUTICALS, INC.
Taub RebeccaDirectorSell$212.1K
Jan 26MDGL
MADRIGAL PHARMACEUTICALS, INC.
Taub RebeccaDirectorSell$318.6K
Jan 20MDGL
MADRIGAL PHARMACEUTICALS, INC.
Taub RebeccaDirectorSell$1.1M
Jan 13MDGL
MADRIGAL PHARMACEUTICALS, INC.
Taub RebeccaDirectorSell$132.1K
Jan 13MDGL
MADRIGAL PHARMACEUTICALS, INC.
Taub RebeccaDirectorSell$9.6M
Dec 12MDGL
MADRIGAL PHARMACEUTICALS, INC.
Taub RebeccaDirectorSell$10.3M
Aug 13MDGL
MADRIGAL PHARMACEUTICALS, INC.
Taub RebeccaDirectorSell$16.5M
Jul 22MDGL
MADRIGAL PHARMACEUTICALS, INC.
Taub RebeccaDirectorSell$350.0K
Jul 18MDGL
MADRIGAL PHARMACEUTICALS, INC.
Taub RebeccaDirectorSell$10.3M

10 filings